NATIONAL TRANSPORTATION SAFETY BOARD SAFETY RECOMMENDATION, I-00-5

This safety recommendation, addressed to the Honorable Jane E. Henney, M.D., Commissioner, U.S. Food and Drug Administration (FDA), recommends that the FDA: Establish a clear, consistent, easily recognizable warning label for all prescription and over-the-counter medications that may interfere with an individual's ability to operate a vehicle; and require that the label be prominently displayed on all packaging of such medications (I-00-5).

• Record URL:
  http://www.ntsb.gov/safety/safety-recs/recletters/I00_5.pdf
• 
• Corporate Authors:

  National Transportation Safety Board

  800 Independence Avenue, SW
  Washington, DC  United States  20594
• Authors:
  • HALL, J
• Publication Date: 2000-1-13

Language

• English

Media Info

• Features: Appendices;
• Pagination: 26 p.

Subject/Index Terms

• TRT Terms: Labeling; Medication; Recommendations; Transportation safety
• Identifier Terms: U.S. Food and Drug Administration
• Subject Areas: Research; Safety and Human Factors;

Filing Info

• Accession Number: 00796977
• Record Type: Publication
• Source Agency: National Highway Traffic Safety Administration
• Report/Paper Numbers: HS-042 981
• Files: HSL, USDOT
• Created Date: Aug 21 2000 12:00AM